Cash-flow ResilienceOperating cash flow rising to HKD 9.13M in 2025 demonstrates durable cash generation separate from accounting profits. Sustained OCF supports working capital and modest capex funding, reduces near-term refinancing need, and gives management flexibility to navigate a 2–6 month horizon.

Strong FCF ConversionA strong free cash flow to net income ratio despite reported accounting losses indicates efficient cash conversion. This reduces reliance on external funding, helps preserve liquidity while pursuing operations or small investments, and materially improves operational durability.

Operational Margin ImprovementThe slight EBITDA margin lift to 13.9% shows management has extracted operating efficiencies despite revenue pressure. Sustained incremental margin gains enhance cash generation potential, help cover fixed costs, and provide a foundation for longer‑term margin recovery if continued.

Bears Say

High LeverageA debt-to-equity ratio of 5.44 and an equity ratio of 7.3% indicate a thin equity cushion and heavy leverage. This materially limits financial flexibility, raises refinancing and solvency risk during industry stress, and constrains investment or strategic moves over the medium term.

Declining Gross MarginA drop in gross margin from 80.2% to 50.7% signals structural cost increases or pricing pressure. Sustained margin erosion reduces per-unit profitability and the company's ability to absorb fixed costs, making durable recovery and long-term profitability more challenging without strategic changes.

Revenue Contraction And Persistent LossesAn 8.2% revenue decline alongside three years of negative net margins indicates ongoing demand or execution issues. Persistent top-line weakness and losses limit scale economics and reinvestment capacity, undermining sustainable growth and prolonging the path to meaningful profitability.

8307 FAQ

What was Medicskin Holdings Ltd.’s price range in the past 12 months?

Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.24 in the past 12 months.

What is Medicskin Holdings Ltd.’s market cap?

Medicskin Holdings Ltd.’s market cap is HK$63.48M.

When is Medicskin Holdings Ltd.’s upcoming earnings report date?

Medicskin Holdings Ltd.’s upcoming earnings report date is Jun 22, 2026 which is in 97 days.

How were Medicskin Holdings Ltd.’s earnings last quarter?

Medicskin Holdings Ltd. released its earnings results on Nov 24, 2025. The company reported HK$0 earnings per share for the quarter, the consensus estimate of N/A by HK$0.

Is Medicskin Holdings Ltd. overvalued?

According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medicskin Holdings Ltd. pay dividends?

Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of N/A. See more information on Medicskin Holdings Ltd. dividends here

What is Medicskin Holdings Ltd.’s EPS estimate?

Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medicskin Holdings Ltd. have?

Medicskin Holdings Ltd. has 396,736,000 shares outstanding.

What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?

Medicskin Holdings Ltd. reported an EPS of HK$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -23.684%.

Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?

Currently, no hedge funds are holding shares in HK:8307

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medicskin Holdings Ltd.

Medicskin Holdings Ltd. (8307) is a leading healthcare company specializing in advanced dermatological and aesthetic solutions. The company operates in the medical and cosmetic sectors, offering a range of products and services designed to enhance skin health and appearance. Medicskin is known for its innovative skincare products, medical devices, and aesthetic treatments, catering to both consumers and healthcare professionals.